Search Results
Department of Medicine, Monash University, Clayton, Victoria, Australia
Search for other papers by Jun Yang in
Google Scholar
PubMed
Search for other papers by Morag J Young in
Google Scholar
PubMed
Search for other papers by Timothy J Cole in
Google Scholar
PubMed
Search for other papers by Peter J Fuller in
Google Scholar
PubMed
levels of serum and glucocorticoid-regulated kinase (sgk-1) in the kidney and colon with a time course consistent with an effect of aldosterone on transcription ( Bhargava et al. 2001 ). Sgk-1 directly interacts with Nedd4-2 to block its binding with
Search for other papers by Ken KY Ho in
Google Scholar
PubMed
Search for other papers by Anthony J O’Sullivan in
Google Scholar
PubMed
Search for other papers by Morton G Burt in
Google Scholar
PubMed
Research 18 55 – 64 . ( https://doi.org/10.1016/j.ghir.2007.07.005 ) Burt MG Johannsson G Umpleby AM Chisholm DJ Ho KK 2008b Impact of growth hormone and dehydroepiandrosterone on protein metabolism in glucocorticoid-treated patients . Journal
South Australian Adult Genetics Unit, Royal Adelaide Hospital, Adelaide, Australia
Adelaide Medical School, University of Adelaide, Adelaide, Australia
Search for other papers by Sunita M C De Sousa in
Google Scholar
PubMed
Garvan Institute of Medical Research, Sydney, NSW, Australia
St Vincent’s Clinical School, University of New South Wales, Sydney, NSW, Australia
Search for other papers by Nèle F Lenders in
Google Scholar
PubMed
St Vincent’s Clinical School, University of New South Wales, Sydney, NSW, Australia
Search for other papers by Lydia S Lamb in
Google Scholar
PubMed
Academy for Medical Education, Faculty of Medicine, the University of Queensland, Brisbane, Australia
Search for other papers by Warrick J Inder in
Google Scholar
PubMed
Garvan Institute of Medical Research, Sydney, NSW, Australia
St Vincent’s Clinical School, University of New South Wales, Sydney, NSW, Australia
Search for other papers by Ann McCormack in
Google Scholar
PubMed
glucocorticoid receptor) ( Miao et al. 2021 ) in corticotrophinomas; SF3B1 in prolactinomas ( Li et al. 2020 ); ATRX ( Casar-Borota et al. 2021 ) and TP53 ( Sbiera et al. 2019 ) in aggressive corticotrophinomas; AHR in somatotrophinomas ( Re et